Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07807826) titled 'A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis (NEZHA-3)' on Sept. 2.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Beijing Keymed Biosciences Co., Ltd.
Condition:
Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP)
Intervention:
Biological: CM512
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: October 2026
Target Sample Size: 240
Countries of Recruitment:
Ch...